The Food and Drug Administration said it would add new warnings to packaging for Neurontin, Lyrica and generic versions, which are used to treat seizures, nerve pain, restless leg syndrome and other conditions.
from Section Page News - Modern Healthcare https://ift.tt/2sR0TCZ
via IFTTT
Get access to the Ultimate Professional Medical Tourism Agent Online Course
No comments:
Post a Comment